Complete the primary DTaP series with PEDIARIX

PEDIARIX helps maintain your well-established primary series DTaP routine*

PEDIARIX has been the foundation of GSK’s DTaP-containing vaccine portfolio since 20022,*,†

Complete the primary DTaP series with PEDIARIX2,4
Vaccine Birth 2 Months 4 Months 6 Months
Hepatitis B Hepatitis B

DTaP=diphtheria, tetanus, and acellular pertussis.

IPV=inactivated poliovirus vaccine.

  • PEDIARIX as a primary series: Three doses of 0.5 mL each, by intramuscular injection, at 2, 4, and 6 months of age (at intervals of 6 to 8 weeks, preferably 8 weeks)2
  • The first dose may be given as early as 6 weeks of age (prior to the 7th birthday)2
  • According to the Centers for Disease Control and Prevention (CDC), administration of a total of 4 doses of hepatitis B vaccine is permitted when a combination vaccine containing hepatitis B is administered after the birth dose4
  • A 3-dose series of PEDIARIX may be administered to infants born of HBsAg-negative mothers and who received a dose of hepatitis B vaccine at or shortly after birth. However, data are limited regarding the safety of PEDIARIX in such infants
  • When a catch-up schedule is needed, the flexibility of PEDIARIX enables you to complete the primary series2,4

A 3-dose series of PEDIARIX constitutes a primary series immunization course for2,4:

And completes the vaccination course for hepatitis B

* Data are not available on the safety and effectiveness of using PEDIARIX following one or more doses of a DTaP vaccine from a different manufacturer.
GSK’s DTaP-containing vaccines are to be administered according to their approved indications.
How the GSK suite of pediatric vaccines help fit the immunization schedule